Search results

Conference Paper (15)

2003
Conference Paper
Reichl, U.; Genzel, Y.; Möhler, L.; Sidorenko, Y.; Sann, H.: Animal cell cultures for the production of viral vaccines. In: GVC/DECHEMA Vortrags- und Diskussiontagung "Zellkulturen: vom biologischen System zum Produktionsprozess", pp. 32 - 35. GVC/DECHEMA : Vortrags- und Diskussionstagung, Bad Dürkheim, Deutschland, May 26, 2003 - May 28, 2003. (2003)
2001
Conference Paper
Genzel, Y.; Voges, L.; Reichl, U.: Development of bioprocess concepts on vaccine production: influenza virus as an example. In: Animal cell technology: from target to market, pp. 344 - 346 (Eds. Lindner-Olsson, E.; Chatzissavidou, N.; Luellau, E.). 17th ESACT Meeting, Tylösand, Sweden, June 10, 2001 - June 14, 2001. (2001)

Meeting Abstract (15)

2019
Meeting Abstract
Hein, M.; Tapia, F.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , October 06, 2019 - October 10, 2019. (2019)
Meeting Abstract
Marichal-Gallardo, P.; Genzel, Y.; Börner, K.; Grimm, D.; Wolff, M. W.; Reichl, U.: A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, January 27, 2019 - January 31, 2019. (2019)
2018
Meeting Abstract
Bissinger, T.; Reichl, U.; Genzel, Y.; Wu, Y.; Liu, X.; Tan, W.-S.: Highly efficient influenza virus production: A MDCK-based high-cell-density process. In Vaccine Technology VII, 13. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Coronel, J.; Genzel, Y.; Reichl, U.; Behrendt, I.; Buergin, T.; Andereli, T.; Sandig, V.: Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Gränicher, G.; Genzel, Y.; Reichl, U.; John, K.; Sandig, V.; Karlas, A.: A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Marichal-Gallardo, P.; Fortuna, A. R.; Genzel, Y.; Wolff, M. W.; Reichl, U.: Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Nikolay, A.; Genzel, Y.; Schwamborn, K.; Leon, A.; Reichl, U.: Flavivirus production in perfusion processes using the EB66® cell line. In Vaccine Technology VII, 80. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Wu, Y.; Liu, X.; Tan, W.-S.; Bissinger, T.; Genzel, Y.; Reichl, U.: Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined medium. In Vaccine Technology VII, 5. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
2017
Meeting Abstract
Tapia, F.; Genzel, Y.; Reichl, U.; Sandig, V.: Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
2014
Meeting Abstract
Fernandes, P.; Castro, R.; Laske, T.; Genzel, Y.; Kremer, E.; Alves, P.; Coroadinha, A.: The impact of MDCK cell source on the production of influenza and canine adenovirus. In New Biotechnology: Abstracts of the 16th European Congress on Biotechnology, 31 Supplement, p. S180. (2014)
2011
Meeting Abstract
Janke, R.; Genzel, Y.; Wetzel, M.; Reichl, U.: Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. In BMC Proceedings, 5 (S8 ), P129. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Meeting Abstract
Roedig, J.; Rapp, E.; Genzel, Y.; Reichl, U.: Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, 5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies , Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
2010
Meeting Abstract
Vester, D.; Rapp, E.; Kluge, S.; Genzel, Y.; Reichl, U.: Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), p. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. (2010)
2009
Meeting Abstract
Öncül, A.; Kalmbach, A.; Genzel, Y.; Reichl, U.; Thevenin, D.: Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 81 (8), p. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, September 08, 2009 - September 10, 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)
2006
Meeting Abstract
Sidorenko, Y.; Dauner, M.; Genzel, Y.; Reichl, U.: Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, p. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, October 01, 2006 - October 05, 2006. (2006)

Talk (88)

2020
Talk
Genzel, Y.: Process intensification for virus production: stirred or shaken perfusion leads to very high titres. World Vaccine Congress Washington, Virtual Meeting (2020)
Talk
Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2020, Virtual Meeting (2020)
Talk
Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2020, Virtual Meeting (2020)
Go to Editor View